Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

(2012) Naga Chalasani et al.   HEPATOLOGY

NAFLD in the Absence of Metabolic Syndrome: Different Epidemiology, Pathogenetic Mechanisms, Risk Factors for Disease Progression?

(2012) Yusuf Yilmaz   SEMINARS IN LIVER DISEASE

Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome

(2011) Yusuf Yilmaz et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

A case–control histological study on the effects of phlebotomy in patients with chronic hepatitis C

(2011) Massimo Sartori et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States

(2011) Michael R. Charlton et al.   GASTROENTEROLOGY

Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial

(2011) Claudia O. Zein et al.   HEPATOLOGY

Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease

(2011) Kris V. Kowdley et al.   HEPATOLOGY

Endpoints and clinical trial design for nonalcoholic steatohepatitis

(2011) Arun J. Sanyal et al.   HEPATOLOGY

Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease

(2010) James E. Nelson et al.   HEPATOLOGY

Patients with Chronic Hepatitis C May be More Sensitive to Iron Hepatotoxicity than Patients with HFE-Hemochromatosis

(2010) Hisao Hayashi et al.   INTERNAL MEDICINE

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

(2010) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling--a propensity score-adjusted observational study

(2010) L. Valenti et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Lifestyle Modification as the Primary Treatment of NASH

(2009) Brent A. Neuschwander-Tetri   Clinics in Liver Disease

HFE Genotype, Parenchymal Iron Accumulation, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2009) Luca Valenti et al.   GASTROENTEROLOGY

Haemoglobin and non-alcoholic fatty liver disease: further evidence from a population-based study

(2009) L. Xu et al.   GUT

Iron Overload: Consequences, Assessment, and Monitoring

(2009) Ali T. Taher et al.   HEMOGLOBIN

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

(2009) Kittichai Promrat et al.   HEPATOLOGY

Decreased survival of subjects with elevated liver function tests during a 28-year follow-up

(2009) Cecilia Söderberg et al.   HEPATOLOGY

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease

(2009) Vincent Wai-Sun Wong et al.   HEPATOLOGY

Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study

(2008) Winston Dunn et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis

(2008) M. J. Wood et al.   BLOOD

Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells

(2008) Richard G. Ruddell et al.   HEPATOLOGY

Hyperferritinemia Is Associated with Insulin Resistance and Fatty Liver in Patients without Iron Overload

(2008) Robert Brudevold et al.   PLoS One